Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

• Status: Withdrawn
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: All

Summary

We hypothesize that the anabolic effects of growth hormone (GH) will improve the clinical status of patients with CF by improving lean body mass, osteopenia, muscle strength, pulmonary function, and quality of life.

We will recruit 40 malnourished CF patients for this 12-month study. All 40 patients will be treated with recombinant human growth hormone (rhGH). Each patient will serve as his/her own control by obtaining medical records for 6 months to 1 year prior to study enrollment or by completing 6 months of study without GH prior to being treated for 1 yr. with GH.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Texas Southwestern Medical Center
• Collaborator: Dana S Hardin
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Age 6 - 40 years

• less than 100% of ideal body weight.

Exclusion Criteria:

• Colonization with Burkholderia cepacia

• pregnancy.